Ababax Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

Ababax General Information

Description

Manufacturer of digital drug delivery products designed to treat depression, anxiety, myopia and cognitive decline. The company specializes in non-invasive brain stimulation technologies delivered via consumer devices such as a standard smartphone using the findings from neuroscience, machine learning and psychology, thereby helping to alter the communication between neuron populations and brain regions.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Friedrichstraße 68
  • 10117 Berlin
  • Germany
+49 030
Primary Industry
Drug Delivery
Parent Company
Eternity.Health
Vertical(s)
Corporate Office
  • Friedrichstraße 68
  • 10117 Berlin
  • Germany
+49 030

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ababax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Merger/Acquisition Completed Generating Revenue
To view Ababax’s complete valuation and funding history, request access »

Ababax Patents

Ababax Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4402688-A1 A computing system for treatment of a neural disorder Pending 15-Sep-2021
US-20240374863-A1 A computing system for treatment of a neural disorder Pending 15-Sep-2021

Ababax Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ababax Investments (1)

Ababax’s most recent deal was a Early Stage VC with Dopavision for . The deal was made on 14-Jul-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Dopavision 14-Jul-2021 Early Stage VC Therapeutic Devices
To view Ababax’s complete investments history, request access »

Ababax FAQs

  • When was Ababax founded?

    Ababax was founded in 2019.

  • Where is Ababax headquartered?

    Ababax is headquartered in Berlin, Germany.

  • What is the size of Ababax?

    Ababax has 7 total employees.

  • What industry is Ababax in?

    Ababax’s primary industry is Drug Delivery.

  • Is Ababax a private or public company?

    Ababax is a Private company.

  • What is Ababax’s current revenue?

    The current revenue for Ababax is .

  • Who acquired Ababax?

    Ababax was acquired by Eternity.Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »